Have a personal or library account? Click to login
Drug discovery for periodontitis Cover
Open Access
|Jun 2020

References

  1. Williams RC. Periodontal disease. N Engl J Med. 1990; 322:373.
  2. Laudenbach JM, Simon Z. Common dental and periodontal diseases: evaluation and management. Med Clin North Am. 2014; 98:1239–60. Epub 2014 Oct 18.
  3. Steele RM, Schuna AA, Schreiber RT. Calcium antagonist-induced gingival hyperplasia. Ann Intern Med. 1994; 120:663–4.
  4. Beck JD, Offenbacher S. The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review. Ann Periodontol. 2001; 6:9.
  5. Offenbacher S, Katz V, Fertik G, Collins J, Boyd D, Maynor G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol. 1996; 67(10 Suppl):1103.
  6. Hayes C, Sparrow D, Cohen M, Vokonas PS, Garcia RI. The association between alveolar bone loss and pulmonary function: the VA dental longitudinal study. Ann Periodontol. 1998; 3:257.
  7. Burt B, Research, science and therapy committee of the American Academy of periodontology. Position paper: epidemiology of periodontal diseases. J Periodontol. 2005; 76:1406.
  8. Ramalingam AK, Selvi SGA, Jayaseelan VP. Targeting prolyl tripeptidyl peptidase from Porphyromonas gingivalis with bioactive compounds from Rosmarinus officinalis. Asian Biomed (Res Rev News). 2019; 13:197–203.
DOI: https://doi.org/10.1515/abm-2019-0056 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415
Language: English
Page range: 171 - 171
Published on: Jun 4, 2020
Published by: Chulalongkorn University
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2020 , published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.